2016
DOI: 10.7324/japs.2016.60804
|View full text |Cite
|
Sign up to set email alerts
|

Bioadhesive HPMC Gel Containing Gelatin Nanoparticles for Intravaginal Delivery of Tenofovir

Abstract: The aim of the present study is to formulate tenofovir loaded gelatin nanoparticles by two step desolvation method for targeted release of drug by varying the concentration of polymer and cross-linking agent. Entrapment efficiency for all the formulations was found to be within 67.32 ± 1.24 % to 92.11 ± 1.13 %. Average particle size of different tenofovir loaded gelatin nanoparticle formulations was found within the range of 294.9 -445.3 nm. In-vitro drug release study for glutaraldehyde cross linked gelatin n… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
10
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(14 citation statements)
references
References 23 publications
1
10
0
Order By: Relevance
“…The spread diameter (Φ) was measured after 1 min. [29][30][31][32] The measurements were done 3 times, and the results were represented as a mean value ± SD.…”
mentioning
confidence: 99%
“…The spread diameter (Φ) was measured after 1 min. [29][30][31][32] The measurements were done 3 times, and the results were represented as a mean value ± SD.…”
mentioning
confidence: 99%
“…From the data attained, it can be said that an increase in HPMC concentration results in a less spreadability of the prepared in situ gelling liquid suppository formulations. A high viscosity and bioadhesive property of the HPMC K15M could be responsible for this decline in the spreadability [56] .…”
Section: Resultsmentioning
confidence: 99%
“…Tenofovir vaginal gel has been investigated within the prevention of HIV. Gelatin nanoparticles of Tenofovir were ready by 2 step desolvation methodology HPMC K15M was used as a bio adhesive compound in addition as a gelling agent [150].…”
Section: Vaginal Drug Deliverymentioning
confidence: 99%